alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 884.5460 Scented or scented deodorized menstrual tampon. ( a ) *Identification.* A scented or scented deodorized menstrual tampon is a device that is a plug made of cellulosic or synthetic material that is inserted into the vagina and used to absorb menstrual or other vaginal discharge. It has scent (i.e., fragrance materials) added for aesthetic purposes (scented menstrual tampon) or for deodorizing purposes (scented deodorized menstrual tampon). This generic type of device does not include menstrual tampons treated with added antimicrobial agents or other drugs.
( b ) *Classification.* Class II (performance standards).
[45 FR 12684, Feb. 26, 1980, as amended at 45 FR 51186, Aug. 1, 1980]
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.2875 Balanced salt solutions or formulations. ( a ) *Identification.* A balanced salt solution or formulation is a defined mixture of salts and glucose in a simple medium. This device is included as a necessary component of most cell culture systems. This media component controls for pH, osmotic pressure, energy source, and inorganic ions.
( b ) *Classification.* Class I (general controls). These devices are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 864.9.
[45 FR 60586, Sept. 12, 1980, as amended at 54 FR 25044, June 12, 1989; 66 FR 38789, July 25, 2001]
#### § 1.1446-7 Applicability dates.

Sections 1.1446-1 through 1.1446-5 shall apply to partnership taxable years beginning after May 18, 2005. However, a partnership may elect to apply all of the provisions of §§ 1.1446-1 through 1.1446-5 to partnership taxable years beginning after December 31, 2004. A partnership shall make the election under this section by complying with the provisions of §§ 1.1446-1 through § 1.1446-5 and attaching a statement to the Form 8804 or Form 1042 annual return, filed for the taxable year in which the regulation provisions first apply, that indicates that the partnership is making the election under this section. The revisions to §§ 1.1446-3(b)(2), 1.1446-3(b)(3)(i)(A) and 1.1446-5(c)(2) contained in the final regulations published in 2008 apply to partnership taxable years beginning after December 31, 2007. See § 1.1446-6(f) and (g) for the Effective/Applicability date and Transition rule for § 1.1446-6. Section 1.1446-3 generally applies to returns filed on or after January 30, 2020 and § 1.1446-3T (as contained in 26 CFR part 1, revised as of April 1, 2019) generally applies to returns filed before January 30, 2020. The addition of § 1.1446-3(c)(4) applies to transfers of partnership interests that occur on or after January 29, 2021, except that a taxpayer may choose to apply § 1.1446-3(c)(4) to transfers of partnership interests that occur on or after January 1, 2018. Sections 1.1446-3(a)(2)(i), (d)(2)(vi), and (e)(4) and 1.1446-4(f)(1) apply to partnership taxable years beginning on or after November 30, 2020. For partnership taxable years beginning before November 30, 2020, see those sections as in effect and contained in 26 CFR part 1, revised as of April 1, 2020. Section 1.1446-4(b)(3) and (4), (c), (d), (e), and (f)(3) apply to distributions made on or after January 1, 2022. For distributions made before January 1, 2022, see §§ 1.1446-4(b)(3) and (4), (c), (d), (e), and (f)(3), as contained in 26 CFR part 1, revised as of April 1, 2020. Sections 1.1446-1(c)(2)(ii)(G) and (H) and 1.1446-2(b)(4)(iii) apply with respect to dispositions of U.S. real property interests and distributions described in section 897(h) occurring on or after December 29, 2022. For dispositions of U.S. real property interests and distributions described in section 897(h) occurring before December 29, 2022, see §§ 1.1446-1(c)(2)(ii)(G) and (H), as contained in 26 CFR part 1, revised as of April 1, 2021.

[T.D. 9200, 70 FR 28717, May 18, 2005, as amended by T.D. 9394, 73 FR 23085, Apr. 29, 2008; T.D. 9926, 85 FR 76935, Nov. 30, 2020; T.D. 9971, 87 FR 80067, Dec. 29, 2022]
### secretaryChu From: WEBMASTER,DOE Sent: To: Tuesday,August28,20121:47AM SecretaryChu Subject: Formsubmissionfrom:ContactUs
Submitted on Tue, 08/28/2012

- 01:47 Submitted by anonymous user: [98.250.111.5] Submitted values are: Topic orcategory: Energy Efficiency Affiliation: General Public Subject: New HVAC standards Message: Hello, I am the president ofmy condominium association in Ann Arbor, Michigan. We are a converted apartment complex, and our buildings are composed of all flats, stacked three-high. Our furnaces and AC units are in furnace closets accessible from the patio or balcony ofeach unit. Since we are a condominium complex, thefurnaces are owned individuallyby each resident. The new HVAC efficiency standards set togo intoeffect on May 1, 2013 will cause a lot of problems for us. Due tothe quasi-outdoor location of our furnaces, we have never been able to use high-efficiencyfurnaces. (Much tomy regret.) The condensation associated with high-efficiency units would freeze the lines, and there are special venting requirements for high-efficiency units that we cannot accommodate. When the new standards go into effect next year, we will be in a real pickle. Our residents buying new furnaces will only be ableto purchase units that will not work in our particular set of circumstances. What recourse do we have? Thank you, David Gurk President, Walden Hills II Condominium Association Ann Arbor, MI Do you want a reply: Yes How should we respond? Email Emailaddress:dgurk@hotmail.com

The results ofthis submission may be viewed at: http://energy.gov/node/268177/submission/39853

1
#### § 1.1411-7 Exception for dispositions of interests in partnerships and S corporations. [Reserved]
Exhibit 15.1

LETTER REGARDING UNAUDITED INTERIM FINANCIAL INFORMATION

Board of
Directors and Shareholders

STERIS Corporation

We are aware of the incorporation by reference in the following Registration Statements and related Prospectuses of our report dated February 9, 2010 relating to the unaudited consolidated interim
financial statements of STERIS Corporation and subsidiaries that are included in its Form 10-Q for the quarter ended December 31, 2009:



|                   |  |                                                                                                                      
|------------------ |  | ---------------------------------------------------------------------------------------------------------------------
|RegistrationNumber |  | Description                                                                                                          
|333-65155          |  | Form S-8 Registration Statement  STERIS Corporation 1998 Long-Term Incentive Compensation Plan                      
|                   | 
|333-32005          |  | Form S-8 Registration Statement  STERIS Corporation 1997 Stock Option Plan                                          
|                   | 
|333-06529          |  | Form S-3 Registration Statement  STERIS Corporation                                                                 
|                   | 
|333-01610          |  | Post-effective Amendment to Form S-4 on Form S-8  STERIS Corporation                                                
|                   | 
|33-91444           |  | Form S-8 Registration Statement  STERIS Corporation 1994 Equity Compensation Plan                                   
|                   | 
|33-55976           |  | Form S-8 Registration Statement  STERIS Corporation 401(k) Plan                                                     
|                   | 
|333-09733          |  | Form S-8 Registration Statement  STERIS Corporation 401(k) Plan                                                     
|                   | 
|333-101308         |  | Form S-8 Registration Statement  STERIS Corporation 2002 Stock Option Plan                                          
|                   | 
|333-91302          |  | Form S-8 Registration Statement  Nonqualified Stock Option Agreement between STERIS Corporation and Mark D. McGinley
|                   | 
|333-137167         |  | Form S-8 Registration Statement  STERIS Corporation Deferred Compensation Plan                                      
|                   | 
|333-136239         |  | Form S-8 Registration Statement  STERIS Corporation 2006 Long-Term Equity Incentive Plan                            

/s/    ERNST & YOUNG LLP

Cleveland, Ohio

February 9, 2010
California Environmental Protection Agency
 

AIR RESOURCES BOARD
 

Executive Order 5-09-014
 

WHEREAS, Attachment A hereto sets forth the currently effective version of the 

California Regulation for Reducing Emissions from Consumer Products (title 17, 

California Code of Regulations, Subchapter 8.5, Article 2, sections 94508-94517 

(Consumer Products Regulation), as adopted by the California Air Resources Board; 

WHEREAS, Attachment B hereto identifies the regulatory action in which the 

Air Resources Board amended the Consumer Products Regulation set forth in 

Attachment A; 

WHEREAS, the Consumer Products Regulation set forth in Attachment A incorporates 

all of the amendments made by the regulatory action identified in Attachment B; 

WHEREAS, the Air Resources Board is authorized to adopt, amend, and enforce the 

referenced regulation by California Health and Safety Code sections 39600,39601, 

39607, and 41712; 

WHEREAS, the referenced regulation has been duly adopted and amended by the Air 

Resources Board through regulatory actions taken in accordance with the California 

Administrative Procedure Act as set forth in Chapter 3.5 (commencing with section 

11340), Part 1, Division 3, Title 2, of the Government Code, and in accordance with 

other applicable laws; 

WHEREAS, the regulatory action incorporated in and reflected by the referenced 

regulation was approved by the California Office of Administrative Law, and thereafter 

became effective under State law; 

WHEREAS, the Air Resources Board is authorized by California Health and Safety 

Code sections 39601 and 39602 to adopt and amend its regulations as revisions to the 

State of California Implementation Plan for AchieVing and Maintaining the National 

Ambient Air Quality Standards (SIP); 

WHEREAS, the adoption of the regulation set forth in Attachment A as a revision to the 

SIP is necessary to meet the requirements of the federal Clean Air Act; and 

WHEREAS, by the Resolution 08-30 and Executive Order R-08-016, the Air Resources 

Board adopted the regulatory action identified in Attachment B, and directed the 

Executive Officer to submit this material to the United States Environmental Protection 

Agency for inclusion in the SIP, and to include in the SIP revisions any additional 

documentation identified as necessary for approvability under the federal Clean Air Act 

1 
and United States Environmental Protection Agency Regulations; 

THEREFORE, IT IS ORDERED, pursuant to sections 39515 and 39516 of the 

California Health and Safety Code, that the regulation set forth in Attachments A and B 

hereto is hereby adopted as a revision to the SIP and forwarded to the 

U.S. Environmental Protection Agency. 

I certify, pursuant to 40 Code of Federal Regulations, 51.1 02(f), that the regulation set 

forth in Attachments A and B was adopted or amended after notice and public hearings 

as required by 40 Code of Federal Regulations 51.102(d). 

Execdted this //fit day of >.U£l/fJ"pj)/ , 2010, at Sacramento, California. 

(7 

Enclosure 

2
Editorial Note on Part 888
Editorial Note: Nomenclature changes to part 888 appear at 73 FR 35341, June 23, 2008.

§ 888.3320 Hip joint metal/metal semi-constrained, with a cemented acetabular component, prosthesis. ( a ) *Identification.* A hip joint metal/metal semi-constrained, with a cemented acetabular component, prosthesis is a two-part device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that consist of a femoral and an acetabular component, both made of alloys, such as cobalt-chromium-molybdenum. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).
( b ) *Classification.* Class III.
( c ) *Date PMA or notice of completion of PDP is required.* A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before May 18, 2016, for any hip joint metal/metal semi-constrained prosthesis with a cemented acetabular component that was in commercial distribution before May 28, 1976, or that has, on or before May 18, 2016, been found to be substantially equivalent to a hip joint metal/metal semi-constrained prosthesis with a cemented acetabular component that was in commercial distribution before May 28, 1976. Any other hip joint metal/metal semi-constrained prosthesis with a cemented acetabular component shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
[52 FR 33702, Sept. 4, 1987, as amended at 81 FR 8149, Feb. 18, 2016]
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.4250 Cryogenic surgical device. ( a ) *Identification.* A cryogenic surgical device is a device used to destroy nervous tissue or produce lesions in nervous tissue by the application of extreme cold to the selected site.
( b ) *Classification.* Class II (performance standards).
# Fourth Court of Appeals

**San Antonio, Texas**

August 20, 2015

N o. 04

- 15

- 00397

- CV

ESTATE OF LUISA R. MONTEMAYOR

,

From the Probate Court No 2, Bexar County, Texas

Trial Court No. 2010

- PC

- 3012

Honorable Tom Rickhoff, Judge Presiding



### ORDER

The Appellant ’s Motion for Extension of Time to File Brief has this d ate been received

and filed in the above styled and numbered cause. Extension of time to file the Appellant’s brief

is this date GRANTED. Time is extended to September 1 5 , 2015.



### PER CURIAM

ATTESTED TO:

____________________________ KEITH E. HOTTLE

CLERK OF COURT

cc: Marcelo R. Montemayor

PO Box 831651

San Antonio, TX 78283 Reed Greene

Reed Greene Law Office

26254 IH 10 West

Suite 135

Boerne, TX 78006
exhibit04_b11.htm - Generated by SEC Publisher for SEC Filing



  





 



 


EXHIBIT 4.(b)(11)


São Paulo, August 8th, 2016


 


To
Casino, Guichard-Perrachon 
148, rue de l’Université
75007 Paris


 


Attn: Jean-Charles Naouri


 


RE: Project Delphes – Commitment letter


 


Dear Sirs,


 


We hereby inform you that, on this date, the Board of Directors of Companhia Brasileira de Distribuição (“Company”) has unanimously resolved that the Company (i) shall cause its voting rights to be exercised at any shareholders meeting of Cnova N.V. (“Cnova”) in favor of the reorganization between Via Varejo S.A. and the Brazilian subsidiary of Cnova, Cnova Comércio Eletrônico S.A., as agreed under Reorganization Agreement; and (ii) will not tender any of its Cnova shares, held directly or indirectly, in the cash tender offers that Casino, Guichard-Perrachon has undertaken to launch for the ordinary shares of Cnova upon completion of the reorganization (the “Tender Offers”), nor to dispose of or transfer, directly or indirectly, Shares in any other manner or through any other instrument, in particular any derivative instruments, until the end of the Tender Offers. CBD will stand alongside and cooperate with CGP in the subsequent squeeze-out procedure, if any, aimed at having Casino obtain the shares of the remaining Cnova minority shareholders, for the avoidance of doubt excluding CBD shares.


 


Finally, we reiterate our agreement to all the terms of the letter agreement that CGP and CBD have executed, whereby CGP takes certain commitments vis-à-vis CBD in relation to their future relationships as shareholders of Cnova.


 


Yours sincerely,


 


/s/ Ronaldo Iabrudi                               


 


Companhia Brasileira de Distribuição
Ronaldo Iabrudi
Chief Executive Officer
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               JUN-30-1998
<CASH>                                       4,218,878
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                     535,317,762
<DEPRECIATION>                              37,176,705
<TOTAL-ASSETS>                             511,682,654
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                   383,128,652
<OTHER-SE>                                (41,221,969)
<TOTAL-LIABILITY-AND-EQUITY>               511,682,654
<SALES>                                              0
<TOTAL-REVENUES>                            43,684,375
<CGS>                                                0
<TOTAL-COSTS>                               27,148,257
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           6,008,338
<INCOME-PRETAX>                             10,748,979
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         10,748,979
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                10,748,979
<EPS-PRIMARY>                                      .30
<EPS-DILUTED>                                      .30
<FN>
<F1>                                Current Assets and Current Liabilities are
                                    not separated to conform with industry
                                    standards.
<F2>                                Income is from rental income. There are no
                                    Sales or Cost of Goods Sold.
</FN>
        

</TABLE>
<PAGE>
 
                                   EXHIBIT 18



May 14, 1997

To the Board of Directors
of Amax Gold Inc.

Dear Directors:

We have been furnished with a copy of the Company's Form 10-Q for the quarter
ended March 31, 1997.  Note 2 therein describes changes in the method of
determining the cost of inventories from the last-in, first-out to the three-
month rolling average method and to include depreciation in the cost of
inventories.  It should be understood that the preferability of one acceptable
method of inventory accounting over another has not been addressed in any
authoritative accounting literature and in arriving at our opinion expressed
below, we have relied on management's business planning and judgment.  Based
upon our discussions with management and the stated reasons for the changes, we
believe that such changes represent, in your circumstances, the adoption of
preferable alternative accounting principles for inventories in conformity with
Accounting Principles Board Opinion No. 20.

We have not made an audit in accordance with generally accepted auditing
standards of the financial statements of Amax Gold Inc. for the three-month
periods ending March 31, 1997 or March 31, 1996 and, accordingly, we express no
opinion thereon or on the financial information filed as part of the Form 10-Q
of which this letter is to be an exhibit.

Very truly yours,

PRICE WATERHOUSE LLP
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Labor

###### Employment and Training Administration

          - [TA-W-71,466]

Pursuant to Section 223 of the Trade Act of 1974, as amended, an investigation was initiated on June 30, 2009 in response to a company official petition filed on behalf of workers of Borg Warner Diversified Transmission Products, Inc., Muncie, Indiana.

The group of workers employed by the subject firm is covered by an earlier petition (TA-W-71,378) filed on June 22, 2009 that is the subject of an ongoing investigation for which a determination has not yet been issued. Consequently, further investigation in this case would serve no purpose, and the investigation under this petition has been terminated.

Signed at Washington, DC, this 7th day of July 2009.

Richard Church,

Certifying Officer, Division of Trade Adjustment Assistance.

[FR Doc. E9-18060 Filed 7-28-09; 8:45 am]

BILLING CODE 4510-FN-P
Editorial Note on Part 864
Editorial Note: Nomenclature changes to part 864 appear at 73 FR 35341, June 23, 2008.

§ 864.6100 Bleeding time device. ( a ) *Identification.* A bleeding time device is a device, usually employing two spring-loaded blades, that produces two small incisions in the patient's skin. The length of time required for the bleeding to stop is a measure of the effectiveness of the coagulation system, primarily the platelets.
( b ) *Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 864.9.
[45 FR 60604, Sept. 12, 1980, as amended at 63 FR 59225, Nov. 3, 1998]
Editorial Note on Part 888
Editorial Note: Nomenclature changes to part 888 appear at 73 FR 35341, June 23, 2008.

§ 888.3790 Wrist joint metal constrained cemented prosthesis. ( a ) *Identification.* A wrist joint metal constrained cemented prosthesis is a device intended to be implanted to replace a wrist joint. The device prevents dislocation in more than one anatomic plane and consists of either a single flexible across-the-joint component or two components linked together. This generic type of device is limited to a device which is made of alloys, such as cobalt-chromium-molybdenum, and is limited to those prostheses intended for use with bone cement (§ 888.3027).
( b ) *Classification.* Class III.
( c ) *Date PMA or notice of completion of a PDP is required.* A PMA or a notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before December 26, 1996 for any wrist joint metal constrained cemented prosthesis that was in commercial distribution before May 28, 1976, or that has, on or before December 26, 1996 been found to be substantially equivalent to a wrist joint metal constrained cemented prosthesis that was in commercial distribution before May 28, 1976. Any other wrist joint metal constrained cemented prosthesis shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
[52 FR 33702, Sept. 4, 1987, as amended at 61 FR 50711, Sept. 27, 1996]